Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.200 | 19 | 6709693 | synonymous variant | C/T | snv | 0.17 | 0.14 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.882 | 0.200 | 19 | 6709693 | synonymous variant | C/T | snv | 0.17 | 0.14 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.925 | 0.120 | 19 | 6679500 | splice region variant | C/T | snv | 0.52 | 0.50 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.120 | 19 | 6679500 | splice region variant | C/T | snv | 0.52 | 0.50 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.120 | 19 | 6679500 | splice region variant | C/T | snv | 0.52 | 0.50 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
19 | 6690760 | intron variant | C/T | snv | 0.11 | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
19 | 6690760 | intron variant | C/T | snv | 0.11 | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.080 | 19 | 6719308 | frameshift variant | CA/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 19 | 6693033 | missense variant | G/A | snv |
|
0.800 | 1.000 | 4 | 2008 | 2010 | ||||||||||
|
1.000 | 19 | 6709755 | missense variant | G/A | snv | 4.0E-06 |
|
0.700 | 1.000 | 2 | 2008 | 2010 | |||||||||
|
0.925 | 0.160 | 19 | 6710937 | non coding transcript exon variant | G/A | snv | 0.17 | 0.14 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.925 | 0.160 | 19 | 6710937 | non coding transcript exon variant | G/A | snv | 0.17 | 0.14 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
19 | 6706285 | intron variant | G/A | snv | 4.4E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
19 | 6697579 | non coding transcript exon variant | G/A | snv | 1.1E-02 | 4.4E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.040 | 19 | 6686078 | intron variant | G/A | snv | 4.9E-02 | 6.1E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.925 | 0.040 | 19 | 6707118 | missense variant | G/A | snv | 2.2E-03 | 1.9E-03 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
1.000 | 0.040 | 19 | 6701502 | intron variant | G/A | snv | 0.66 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 19 | 6703061 | intron variant | G/A | snv | 0.77 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 19 | 6714208 | missense variant | G/A | snv |
|
0.700 | 1.000 | 1 | 2008 | 2008 | ||||||||||
|
1.000 | 0.080 | 19 | 6681980 | synonymous variant | G/A | snv | 8.4E-02 | 8.5E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.925 | 0.040 | 19 | 6707118 | missense variant | G/A | snv | 2.2E-03 | 1.9E-03 |
|
0.700 | 0 | ||||||||||
|
0.925 | 0.160 | 19 | 6713251 | missense variant | G/A;C | snv | 0.14; 4.0E-06 |
|
Eye Diseases | 0.050 | 0.800 | 5 | 2010 | 2015 | |||||||
|
0.925 | 0.160 | 19 | 6713251 | missense variant | G/A;C | snv | 0.14; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.080 | 19 | 6677978 | synonymous variant | G/A;C | snv | 0.52; 4.0E-06 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||||
|
0.925 | 0.080 | 19 | 6677978 | synonymous variant | G/A;C | snv | 0.52; 4.0E-06 |
|
0.010 | 1.000 | 1 | 2014 | 2014 |